Inhibiting cyprinid herpesvirus-3 replication with CRISPR/Cas9

被引：0

作者：

Yicheng Zhao

Tiedong Wang

Ze Yu

Heming Wang

Bo Liu

Chunyan Wu

Chun-Bo Teng

机构：

[1] Northeast Forestry University,College of Life Sciences

[2] Jilin University,College of Animal Sciences

[3] Inner Mongolia Agricultural University,College of Veterinary Medicine

来源：

Biotechnology Letters | 2016年 / 38卷

关键词：

CRISPR/Cas9; Cyprinid herpesvirus-3; DNA polymerase; Koi herpesvirus; Thymidine kinase;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：573 / 578

页数：5

共 50 条

[21] Making memories with CRISPR–Cas9
Nature Methods, 2016, 13 (11) : 904 - 904
[22] Liposomal delivery of CRISPR/Cas9
Zhen, Shuai
Li, Xu
CANCER GENE THERAPY, 2020, 27 (7-8) : 515 - 527
[23] CRISPR/Cas9 ruling expected
Cross, Ryan
CHEMICAL & ENGINEERING NEWS, 2018, 96 (35) : 12 - 12
[24] Photoactivatable CRISPR/Cas9 System
Akhmetova, E. A.
Golyshev, V. M.
Vokhtantcev, I. P.
Meschaninova, M., I
Venyaminova, A. G.
Novopashina, D. S.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2021, 47 (02) : 496 - 504
[25] CRISPR/Cas9 as a Mutagenic Factor
Shumega, Andrey R.
Pavlov, Youri I.
Chirinskaite, Angelina V.
Rubel, Aleksandr A.
Inge-Vechtomov, Sergey G.
Stepchenkova, Elena I.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
[26] CRISPR screens beyond Cas9
Darren J. Burgess
Nature Reviews Genetics, 2020, 21 : 273 - 273
[27] Photoactivatable CRISPR/Cas9 System
E. A. Akhmetova
V. M. Golyshev
I. P. Vokhtantcev
M. I. Meschaninova
A. G. Venyaminova
D. S. Novopashina
Russian Journal of Bioorganic Chemistry, 2021, 47 : 496 - 504
[28] Controlling CRISPR–Cas9 activity
Sarah Crunkhorn
Nature Reviews Drug Discovery, 2019, 18 (7) : 500 - 500
[29] Anything impossible with CRISPR/Cas9?
Renjie Jiao
Caixia Gao
Science China(Life Sciences) , 2017, (05) : 445 - 446
[30] CRISPR/Cas9 and gene therapy
Giono, Luciana E.
MEDICINA-BUENOS AIRES, 2017, 77 (05) : 405 - 409